GlassScriptPhysician profile
Joseph Hamati
NPI 1033599410
$2,338.22
in general payments reported to CMS, 2019-2025
15 companies · $14.96 in 2025
The $14.96 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,244 · 2020: $271 · 2021: $422 · 2022: $386 · 2025: $14.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $999.76 | 2019-2020 | |
| Medtronic, INC. | $535.33 | 2021-2025 | Inceptiv |
| Nevro Corp. | $249.82 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $121.61 | 2019 | |
| Merck Sharp & Dohme LLC | $102.46 | 2019-2021 | |
| Si-Bone, INC. | $81.30 | 2020-2021 | |
| Abbott Laboratories | $73.78 | 2021 | |
| Masimo Corporation | $49.93 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $24.25 | 2021 | |
| Mml US, INC. | $20.33 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $19.98 | 2021 | |
| Stimwave Technologies Incorporated | $17.49 | 2021 | |
| Ibsa Pharma INC. | $14.94 | 2021 | |
| Radius Health, INC. | $14.74 | 2021 | |
| Zyla Life Sciences, INC. | $12.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Hamati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.